日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects

TLR5 激动剂恩托利莫德可降低 TNF 的不良毒性,同时保留其抗肿瘤作用

Gary J Haderski, Bojidar M Kandar, Craig M Brackett, Ilia M Toshkov, Christopher P Johnson, Geraldine M Paszkiewicz, Venkatesh Natarajan, Anatoli S Gleiberman, Andrei V Gudkov, Lyudmila G Burdelya

Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma

抗癌候选药物 CBL0137 可抑制组蛋白伴侣 FACT,对替莫唑胺敏感和耐药的胶质母细胞瘤的临床前原位模型有效

Tara A Barone, Catherine A Burkhart, Alfiya Safina, Gary Haderski, Katerina V Gurova, Andrei A Purmal, Andrei V Gudkov, Robert J Plunkett

Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas

单次输注疗法根除肢体黑色素瘤的临床前验证

Kim, Minhyung; Neznanov, Nickolay; Wilfong, Chandler D; Fleyshman, Daria I; Purmal, Andrei A; Haderski, Gary; Stanhope-Baker, Patricia; Burkhart, Catherine A; Gurova, Katerina V; Gudkov, Andrei V; Skitzki, Joseph J

Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist

肝脏在 Toll 样受体 5 激动剂的抗癌和放射防护活性中起着核心作用

Burdelya, Lyudmila G; Brackett, Craig M; Kojouharov, Bojidar; Gitlin, Ilya I; Leonova, Katerina I; Gleiberman, Anatoli S; Aygun-Sunar, Semra; Veith, Jean; Johnson, Christopher; Haderski, Gary J; Stanhope-Baker, Patricia; Allamaneni, Shyam; Skitzki, Joseph; Zeng, Ming; Martsen, Elena; Medvedev, Alexander; Scheblyakov, Dmitry; Artemicheva, Nataliya M; Logunov, Denis Y; Gintsburg, Alexander L; Naroditsky, Boris S; Makarov, Sergei S; Gudkov, Andrei V